NORADRENALINE AGUETTANT 1MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION

AGUETTANT ASIA PACIFIC PTE. LTD.

AGUETTANT ASIA PACIFIC PTE. LTD.

Therapeutic

Prescription Only

INFUSION, SOLUTION CONCENTRATE

**DOSAGE AND ADMINISTRATION** **NORADRENALINE AGUETTANT is a concentrated, potent drug which must be diluted in dextrose containing solutions prior to infusion. An infusion of NORADRENALINE AGUETTANT should be given into a large vein (see PRECAUTIONS** – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ **).** NORADRENALINE AGUETTANT contains no antimicrobial preservative. It is for single use in one patient only. Discard any residue. **Restoration of Blood Pressure in Acute Hypotensive States** Blood volume depletion should always be corrected as fully as possible before any vasopressor is administered. When, as an emergency measure, intraaortic pressures must be maintained to prevent cerebral or coronary artery ischemia, NORADRENALINE AGUETTANT can be administered before and concurrently with blood volume replacement. **Diluent:** NORADRENALINE AGUETTANT should be diluted in 5 percent dextrose injection or 5 percent dextrose and sodium chloride injections. These dextrose containing fluids are protection against significant loss of potency due to oxidation. **Administration in saline solution alone is not recommended.** Whole blood or plasma, if indicated to increase blood volume, should be administered separately (for example, by use of a Y-tube and individual containers if given simultaneously). _Average Dosage:_ Add a 4 mL ampul (4 mg) of NORADRENALINE AGUETTANT to 1,000 mL of a 5 percent dextrose containing solution. Each mL of this dilution contains 4 mcg of the base of NORADRENALINE AGUETTANT. Give this solution by intravenous infusion. Insert a plastic intravenous catheter through a suitable bore needle well advanced centrally into the vein and securely fixed with adhesive tape, avoiding, if possible, a catheter tie-in technique as this promotes stasis. An IV drip chamber or other suitable metering device is essential to permit an accurate estimation of the rate of flow in drops per minute. After observing the response to an initial dose of 2 mL to 3 mL (from 8 mcg to 12 mcg of base) per minute, adjust the rate of flow to establish and maintain a low normal blood pressure (usually 80 mm Hg to 100 mm Hg systolic) sufficient to maintain the circulation to vital organs. In previously hypertensive patients, it is recommended that the blood pressure should be raised no higher than 40 mm Hg below the preexisting systolic pressure. The average maintenance dose ranges from 0.5 mL to 1 mL per minute (from 2 mcg to 4 mcg of base). _High Dosage:_ Great individual variation occurs in the dose required to attain and maintain an adequate blood pressure. In all cases, dosage of NORADRENALINE AGUETTANT should be titrated according to the response of the patient. Occasionally, much larger or even enormous daily doses (as high as 68 mg base or 17 ampuls) may be necessary if the patient remains hypotensive, but occult blood volume depletion should always be suspected and corrected when present. Central venous pressure monitoring is usually helpful in detecting and treating this situation. Dilution can be varied depending on the clinical fluid volume requirement. _Fluid Intake:_ The degree of dilution depends on clinical fluid volume requirements. If large volumes of fluid (dextrose) are needed at a flow rate that would involve an excessive dose of the pressor agent per unit of time, a solution more dilute than 4 mcg per mL should be used. On the other hand, when large volumes of fluid are clinically undesirable, a concentration greater than 4 mcg per mL may be necessary. _Duration of Therapy:_ The infusion should be continued until adequate blood pressure and tissue perfusion are maintained without therapy. Infusions of NORADRENALINE AGUETTANT should be reduced gradually, avoiding abrupt withdrawal. In some of the reported cases of vascular collapse due to acute myocardial infarction, treatment was required for up to six days. **Adjunctive Treatment in Cardiac Arrest** Infusions of NORADRENALINE AGUETTANT are usually administered intravenously during cardiac resuscitation to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means. \[NORADRENALINE AGUETTANT’s powerful beta-adrenergic stimulating action is also thought to increase the strength and effectiveness of systolic contractions once they occur.\] _Average Dosage:_ To maintain systemic blood pressure during the management of cardiac arrest, NORADRENALINE AGUETTANT is used in the same manner as described under Restoration of Blood Pressure in Acute Hypotensive States. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit. Do not use the solution if its color is pinkish or darker than slightly yellow or if it contains a precipitate. For single use only. Avoid contact with iron salts, alkalis, or oxidizing agents.